WebJun 22, 2024 · The EASL Clinical Practice Guidelines (CPGs) on the management of hepatic encephalopathy (HE) present evidence-based answers to a set of relevant questions (where possible, formulated in PICO [patient/population, intervention, comparison and outcomes] format) on the definition, diagnosis, differential diagnosis and treatment of HE. WebBoth AASLD and EASL guidelines recommend TDF for use during pregnancy. 2,4 d VEMLIDY is not recommended in patients with end stage renal disease (ESRD; estimated creatinine clearance [eCrCl] <15 mL/min) who are not receiving chronic hemodialysis; in patients on chronic hemodialysis, on hemodialysis days, administer VEMLIDY after …
EASL The Home of Hepatology
WebFor patients with eCrCl 30-49 mL/min, 10-29 mL/min, and ESRD on chronic hemodialysis, the dosing is every 48 hours, every 72-96 hours, and every 7 days or after a total of approximately 12 hours of dialysis, respectively.6 Entecavir 0.5 mg does not require dosing adjustment in patients with eCrCl ≥50 mL/min. WebTribute to Prof. Peter Ferenci (1948-2024) We have to share the sad news that Peter Ferenci has passed away on 11 April 2024 just a few weeks before his 75th birthday. He recently celebrated his 50 years anniversary at the Medical University of Vienna and fought his declining health over the past months with great dignity and courage, still ... imperatively definition
Screening for Hepatocellular Carcinoma - Hepatitis B Online
WebThe 2024 updated guidance on chronic hepatitis B (CHB) includes (1) updates on treatment since the 2016 HBV guidelines (notably the use of tenofovir alafenamide) and guidance on (2) screening, counseling, and prevention; (3) specialized virological and serological tests; (4) monitoring of untreated patients; and (5) treatment of hepatitis B in … WebEASL Clinical Practice Guidelines: Autoimmune hepatitis EASL Clinical Practice Guidelines: Autoimmune hepatitis J Hepatol. 2015 Oct;63 (4):971-1004. doi: 10.1016/j.jhep.2015.06.030. Author European Association for the Study of the Liver 1 Collaborators European Association for the Study of the Liver : WebHepB Consult from CCO is an easy-to-use, point-of care resource for all healthcare professionals and others affected by hepatitis B. This Interactive Decision Support Tool draws upon expert consensus guidelines to provide customized recommendations on whether and how to treat hepatitis B in a specific patient setting. imperative knowledge 中文